Effects of switching from liraglutide to semaglutide or dulaglutide in patients with type 2 diabetes: A randomized controlled trial

INTRODUCTION: Few studies have examined the effects of glucagon‐like peptide‐1 receptor agonist switching, particularly in Japanese patients. Therefore, we aimed to investigate the effects of switching from liraglutide to semaglutide or dulaglutide on blood glucose, body weight, and the occurrence o...

Descripción completa

Detalles Bibliográficos
Autores principales: Iijima, Takahiro, Shibuya, Makoto, Ito, Yuzuru, Terauchi, Yasuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204181/
https://www.ncbi.nlm.nih.gov/pubmed/36871272
http://dx.doi.org/10.1111/jdi.14000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204181/
https://www.ncbi.nlm.nih.gov/pubmed/36871272
http://dx.doi.org/10.1111/jdi.14000

Ejemplares similares